NeurogesX (NGSX)
NeurogesX Valuation (Historical Mult.)
View NGSX Valuation (Historical Mult.) with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
About Valuation (Historical Mult.)
Valuation (Historical Mult.) is the average of YCharts' individual valuation methods. Since the method is an average, it will tend to be less volatile than either of the individual valuation methods. As a result, we recommend checking the values given by each of the component methods.
If either of the methods is missing for any reason, the fair value is the average of the remaining method.
Learn More
You may also be interested in these NGSX related companies
NGSX News
@gofigure $PPHM $NGSX $GALE short term yes, but Long term no they are not done! All have huge potential for big gains!
about 31 days ago by BiopharmaPro
about 31 days ago by BiopharmaPro
NeurogesX to Hold Conference Call to Discuss First Quarter 2012 Results
Apr 27, 9:00AM GlobeNewswire
Apr 27, 9:00AM GlobeNewswire
$ngsx Hearings are typically scheduled 30 to 45 days from the company's request
about 35 days ago by bood747
about 35 days ago by bood747
@rickz $ngsx supposed to delist tomorrow.I cant find any news on whether thye got a hearing or not.any info?
about 36 days ago by bood747
about 36 days ago by bood747
NeurogesX Receives Determination Letter From NASDAQ; Not Regaining Compliance
Apr 20, 4:06PM Benzinga
Apr 20, 4:06PM Benzinga
No i'm not kidding, 3/4 portfolio in $OCZ 1/4 BIT:ISP $PPHM $NGSX $GALE I'm all IN
about 41 days ago by micheleciani
about 41 days ago by micheleciani
$NGSX performing well today, if will go OUT in the upper part of the triangle in 1 day we go pair http://chart.ly/eutswy8
about 41 days ago by micheleciani
about 41 days ago by micheleciani
NeurogesX (NGSX) Gets FDA Acceptance for End-of-Phase 2 Meeting for NGX-1998
Apr 11, 7:33AM Street Insider
Apr 11, 7:33AM Street Insider
Wedbush Upgrades NeurogesX, Inc. (NGSX) to Outperform; Restructuring Puts NGX-1998 Liquid Formulation On Center Stage
Mar 14, 1:50PM Street Insider
Mar 14, 1:50PM Street Insider
NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Full Year 2011 Results
Feb 29, 8:30AM GlobeNewswire
Feb 29, 8:30AM GlobeNewswire
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
Feb 09, 5:47PM Street Insider
Feb 09, 5:47PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NGSX | 0.37 | +0.00 | +0.00% | 11.07M |
| NGPC | 6.71 | +0.03 | +0.45% | 144.49M |
| NGLS | 40.45 | -0.92 | -2.22% | 3.764B |
| NGG | 50.55 | -2.94 | -5.50% | 39.03B |
| NGB | 16.30 | +0.00 | +0.00% | |
| NFZ | 14.67 | +0.02 | +0.14% | |
| NFX | 30.56 | -1.58 | -4.92% | 4.346B |
| NFP | 13.19 | -0.12 | -0.90% | 536.26M |
| NFO | 31.54 | -0.56 | -1.73% | |
| NFLX | 67.34 | -2.10 | -3.02% | 3.848B |